NCT02570711 Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT02565641 A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02562898 Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02560038 Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer Status TERMINATED Phase PHASE2
NCT02559674 QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel Status COMPLETED Phase PHASE1
NCT02555657 Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119) Status COMPLETED Phase PHASE3
NCT02550327 Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02546531 Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02544243 Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT02542111 A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL Status UNKNOWN Phase PHASE2
NCT02539537 A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma Status COMPLETED Phase PHASE3
NCT02538432 Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors Status WITHDRAWN Phase PHASE2
NCT02537561 Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT02533323 P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens Status TERMINATED Phase PHASE2
NCT02529579 Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02525653 Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers Status COMPLETED Phase PHASE2
NCT02516241 Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02514681 A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT02514421 Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1